Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Operating Activities:    
Net Loss $ (3,457) $ (8,915)
Adjustments to Reconcile Net Income to Net Cash Provided By (Used in) Operating Activities:    
Depreciation 4,742 5,952
Deferred Income Taxes   (5,461)
Reclassification from Accumulated Other Comprehensive Income to Net Loss (4,431) (611)
Cash (Paid) Received on Change in Fair Value of Derivative Instruments (1,140) 12,636
Non-Cash Stock-Based Compensation 3 378
Equity (Earnings) Loss in Unconsolidated Investees (1,358) 665
Other 105 59
Changes in Operating Assets and Liabilities:    
Accounts Receivable 15,810 15,033
Inventories 6,402 5,283
Prepaid Expenses and Other Assets 544 12,823
Accounts Payable-Raw Sugar (15,836) (61,213)
Accounts Payable-Other Trade 495 306
Other Liabilities (6,118) (8,492)
Net Cash Used in Operations (4,239) (31,557)
Investing Activities:    
Capital Expenditures (4,229) (10,065)
Proceeds from Sales of Investments in Unconsolidated Investees 19,737  
Other (24) (57)
Net Cash Provided by (Used in) Investing Activities 15,484 (10,122)
Financing Activities:    
Borrowings (Repayments) under Revolving Credit Line-Net (11,009) 26,000
Cash Dividends   (242)
Other (121) (120)
Net Cash Provided by (Used in) Financing Activities (11,130) 25,638
Increase (Decrease) in Cash and Cash Equivalents 115 (16,041)
Cash and Cash Equivalents, Beginning of Period 134 22,750
Cash and Cash Equivalents, End of Period 249 6,709
Supplemental Non-Cash Items:    
Tax Effect of Deferred Gains and Losses   4,716
Purchase of Property, Plant and Equipment on Account $ 949 $ 4,836